Mealey's (June 6, 2019, 2:01 PM EDT) -- WASHINGTON, D.C. — In supplemental briefs filed June 4, a genetics analysis company and the maker of a purportedly infringing DNA test respond to a recently filed brief by the U.S. government, arguing in the U.S. Supreme Court as to whether certiorari should be granted on a question of patent priority dates and prior art (Ariosa Diagnostics Inc. v. Illumina Inc., No. 18-109, U.S. Sup)....